Background & objectives

Background & objectives


Danish Diabetes Academy (DDA) constitutes an original networking platform for a national diabetes research strategy that is rational and science-based, and which will strengthen both basic and clinical research in diabetes. DDA is expected to foster enhanced collaboration between Danish diabetes research environments and ensure rapid distribution and shared access to novel research results, ideas and technologies, thus benefitting other research groups within the organisation.

  1. Danish Diabetes Academy in brief
  2. Historical background
  3. Vision, mission & objectives


A video promoting DDAs mission, vision and activities recorded during Winter School in Malaga 2017.  

Historical background

Diabetes mellitus – both type 1 diabetes (T1D) and type 2 diabetes (T2D) - is a widespread disease increasing rapidly worldwide. The prevalence increases with around 5 % per year and is close to 10 % for adults. In Denmark we are approaching 300,000 diabetics, thus creating a great challenge – both socioeconomically and medically.

Danish Diabetes Academy (DDA) was established September 1, 2012 with 5-year grant from the Novo Nordisk Foundation of DKK 201,880,000 (EUR 27,059,485). Danish universities and university hospitals provided co-funding totalling DKK 100,000,000.

Since its foundation, DDA has accomplished the following: 

  • Anually DDA has hosted two residential PhD courses, one Winter School for postdocs and more than four national and international seminars. Almost 70% of invited speakers at the seminars were recruited internationally. The average number of participants at the seminars has been over 100.
  • DDA has established a PhD Network of Diabetes and Metabolism, with eight of nine university PhD programmes in Denmark taking part.
  • DDA has organized eight networking activities annually, with the participation of Danish professional societies. The DDA also initiated a flourishing collaboration with international research institutions on PhD courses and postdoctoral training.
  • DDA has financially supported 90 PhD fellowships, 35 national and international postdoctoral fellowships, 12 visiting professorships and one full-time professor. These researchers have published 300 papers, predominantly in high-impact journals.  

January 1, 2018, DDA received a new 5-year grant from the Novo Nordisk Foundation (NNF) of DKK 156,000,000 to support education of the next generation of diabetes researchers, as well as networking and research collaboration initiatives. 

Below you can read the grant application to NNF 2017 and the grant agreement from NNF for the period 2018-2022 that followed:

Vision, mission & objectives

The vision of DDA is to enhance the quality of Danish Diabetes research education in order to ensure that it remains at the highest international level. The mission of DDA is to educate and train the next generation of researchers in the field of diabetes.

The overall objectives of DDA are to:

  • Strengthen the research training available to PhD students and Post Docs within the field of diabetes, in collaboration with academia, hospitals, and life-science industry
  • Serve as a national hub within diabetes, unifying academia, hospitals, and life-science industry in Denmark, to strengthen educational activities and talent development within the area
  • Recruit outstanding national and international PhD students, Post Docs and Visiting Professors, within the field of diabetes, in open and free competition